Semler Scientific Investors Face Deadline to Lead Securities Fraud Lawsuit

Semler Scientific investors have until October 28, 2025, to file a lead plaintiff in a securities fraud lawsuit. The Rosen Law Firm is representing investors who purchased Semler Scientific securities between March 10, 2021, and April 15, 2025. The lawsuit alleges that defendants made false and misleading statements about a material investigation by the US Department of Justice. Investors who purchased Semler Scientific securities during the class period may be entitled to compensation without paying any out-of-pocket fees.

Investors who purchased Semler Scientific, Inc. (NASDAQ: SMLR) securities between March 10, 2021, and April 15, 2025, have until October 28, 2025, to file as lead plaintiffs in a securities fraud lawsuit. The Rosen Law Firm is representing investors who may be entitled to compensation for alleged false and misleading statements made by the company and its officers.

The lawsuit alleges that Semler Scientific did not disclose a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act, while discussing possible violations in hypothetical terms. This failure to disclose, according to the lawsuit, resulted in materially false and misleading statements by the defendants, causing investors to suffer damages when the true details entered the market.

The Rosen Law Firm is encouraging investors to join the class action by visiting https://rosenlegal.com/submit-form/?case_id=39889 or contacting Phillip Kim, Esq., toll-free at 866-767-3653, or via email at case@rosenlegal.com. Investors can also contact Bronstein, Gewirtz & Grossman, LLC, another firm representing investors in the case, at 332-239-2660 or via email at info@bgandg.com.

Investors who wish to serve as lead plaintiffs must move the court no later than October 28, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. It is important to note that an investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

The Rosen Law Firm and Bronstein, Gewirtz & Grossman, LLC, both have extensive experience in securities class actions and have recovered hundreds of millions of dollars for investors. They represent investors on a contingency fee basis, meaning investors do not pay any out-of-pocket fees or costs.